Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.

scientific article published in June 1998

Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00007691-199806000-00007
P698PubMed publication ID9631924

P2093author name stringLevine M
Keown PA
Kovarik JM
Mueller EA
Primmett DR
P433issue3
P921main subjectcyclosporineQ367700
P304page(s)276-283
P577publication date1998-06-01
P1433published inTherapeutic Drug MonitoringQ15724567
P1476titleCyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.
P478volume20

Reverse relations

cites work (P2860)
Q43705339A limited sampling strategy for cyclosporine area under the curve monitoring in lung transplant recipients.
Q36831051Calcineurin inhibitors in pediatric renal transplant recipients
Q77369580Cyclosporine A: peak or trough level monitoring in renal transplant recipients?
Q45046062Cyclosporine levels at 2 hours after dose and body mass index in relation to graft function in renal transplant patients treated with azathioprine or mycophenolate mofetil.
Q44051279Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation
Q35711382Evolution of the therapeutic drug monitoring of cyclosporine
Q35980234Immunosuppressant drug monitoring: is the laboratory meeting clinical expectations?
Q36029868Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome
Q28244228Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients
Q43875084Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants
Q33937533Methods for clinical monitoring of cyclosporin in transplant patients.
Q35154212Nano composite emulsion for sustained drug release and improved bioavailability
Q43828393Neoral drug monitoring in stable kidney allotransplant recipients: C(0) versus C(2).
Q73756670New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients
Q37781449Novel Strategies for Immune Monitoring in Kidney Transplant Recipients
Q43828405Optimization of cyclosporine therapy in the Neoral era: abbreviated AUC, single blood sampling?
Q54475479Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant.
Q83220048Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation
Q73314640Pharmacokinetics of abbreviated AUC of cyclosporine in renal allograft recipients in a Pakistani population
Q44051282Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis
Q33345496Review of the proliferation inhibitor everolimus
Q57605884Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation
Q36742534The CARI guidelines. Calcineurin inhibitors in renal transplantation: therapeutic drug monitoring
Q44187095Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children
Q35710903Use of cyclosporine in renal transplantation
Q51673782Validation of Sparse Sampling Strategies to Estimate Cyclosporine A Area Under the Concentration-Time Curve Using Either a Specific Radioimmunoassay or High-Performance Liquid Chromography Method

Search more.